From unpublished personal observations we would conclude that although pre-activated T cells impair Foxp3 induction in naive T cells, the conversion is not fully abrogated

From unpublished personal observations we would conclude that although pre-activated T cells impair Foxp3 induction in naive T cells, the conversion is not fully abrogated. and function. For example, co-expression of CD49b and LAG-3 BIRT-377 has been reported to specifically identify a population of IL-10Treg cells both in man and mouse.1 However, more recent findings from a study of antigen-specific immunotherapy in a murine model of autoimmune disease suggest that these markers are not specific identifiers of all IL-10Treg cells, with co-expression found on a fraction of IL-10Treg cells but also on other T cells that do not express IL-10.2 Moreover, to distinguish peripherally differentiated Foxp3+ Treg (pTreg) cells from resident thymus-derived Foxp3+ Treg (tTreg) cells, two main differentiating markers, Helios (present on murine and human tTreg but not pTreg cells) and Neuropilin-1 (present only on murine tTreg cells), have been reported, but again neither are undisputed.3C7 This lack of exclusive markers has limited the ability to track and study inducible Treg cells differentiated Treg (iTreg) cells, which are similar but not necessarily identical to differentiated pTreg cells, phenotypically and functionally.8,9 Of course the latter is likely to be the case when BIRT-377 comparing or differentiated IL-10Treg cells as well, although here no formal distinction in nomenclature is made. Despite these shortcomings, we will endeavour to review here the known pros and cons of both subtypes of inducible Treg cell, how to generate them, and their suitability as targets in antigen-specific immunotherapy (ASIT). The natural role of inducible Treg cells in immune regulation To understand the therapeutic potential of inducible Treg cell subsets, it is important to first understand the natural development and function of these cells in the prevention of disease. The first demonstration of the regulatory role of IL-10Treg cells was in patients with severe combined immunodeficiency who received HLA-mismatched haematopoietic stem cell transplants, where donor T cells indicated high quantities of IL-10 and were responsible for tolerance to sponsor antigens.10 A role for IL-10Treg cells in keeping immune homoeostasis to gut flora in mice was suggested after the discovery of their presence in the intestinal lamina propria.11 In 2004, Akdis retinoic acid, secreted by mucosal dendritic cells.19C21 In addition, short-chain fatty acids produced by commensal microorganisms in mice were shown to promote extra-thymic Foxp3 induction in CD4+ T cells that mediate an anti-inflammatory response.22,23 In addition to mucosal BIRT-377 sites, pTreg cells can develop within other peripheral cells. Inside a murine model of uveoretinitis, tissue-resident and locally differentiated pTreg cells safeguarded from retinal damage.24 The pTreg cells have also been reported to develop in response to chronic inflammation resulting from asthma, autoimmune disease or infection and therefore appear to play a role in limiting the tissue damage that inevitably results from long-lasting inflammation, although these findings are not universally supported (as reviewed thoroughly by Bilate and Lafaille25). Interestingly, comparison of various animal models of autoimmune disease, each transporting the same revised version of Foxp3 protein that affects the development of pTreg cells but not tTreg cells, suggests that pTreg cells play a pivotal part in preventing the onset of type 1 diabetes but not arthritis or autoimmune encephalomyelitis.26C28 Disease-specific conditions therefore seem to play an important role in the functionality of pTreg cells. Clearly, both subsets of inducible Treg cells fulfil a varied natural part in immune BIRT-377 homoeostasis and both seem potent, albeit not common, inhibitors of undesirable immune reactions. This supports the notion that the restorative differentiation of these T cells S5mt should be a perfect aim for immunotherapy of hyperimmune conditions. Immune rules by inducible Treg cells; a pivotal part for IL-10 Several mechanisms have been reported for.